Physician profile
Mark Mainous
NPI 1427088079
$133,183.77
in general payments reported to CMS, 2019-2025
10 companies · $19K in 2025
The $19K reported for 2025 was more than what 98% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $142 · 2021: $7,107 · 2022: $68K · 2023: $27K · 2024: $12K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $46K · Travel and Lodging: $9,755 · Food and Beverage: $2,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $45,988.00 |
| Travel and Lodging | $9,754.90 |
| Food and Beverage | $2,411.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $131,557.20 | 2021-2025 | Zynrelef, Aponvie |
| Ethicon US, LLC | $572.76 | 2019-2025 | Echelon; Endopath, Dermabond Prineo, Ethicon |
| Karl Storz Endoscopy-America | $334.21 | 2019-2023 | |
| Sanara Medtech INC. | $261.13 | 2025 | Celleraterx |
| Allergan, INC. | $244.10 | 2021-2022 | |
| Depuy Synthes Sales INC. | $75.43 | 2023 | Xcm Biologic Tissue Matrix, Matrixneuro |
| Davol INC. | $55.21 | 2019-2024 | Phasix Mesh |
| Abbvie INC. | $45.82 | 2023-2024 | |
| Innovation Technologies INC | $23.42 | 2025 | Irrisept |
| Conmed Corporation | $14.49 | 2023 | Airseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Mainous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.